These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9007092)

  • 1. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
    Frey KA; Koeppe RA; Kilbourn MR; Vander Borght TM; Albin RL; Gilman S; Kuhl DE
    Ann Neurol; 1996 Dec; 40(6):873-84. PubMed ID: 9007092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased striatal monoaminergic terminals in Huntington disease.
    Bohnen NI; Koeppe RA; Meyer P; Ficaro E; Wernette K; Kilbourn MR; Kuhl DE; Frey KA; Albin RL
    Neurology; 2000 May; 54(9):1753-9. PubMed ID: 10802780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.
    Bohnen NI; Albin RL; Koeppe RA; Wernette KA; Kilbourn MR; Minoshima S; Frey KA
    J Cereb Blood Flow Metab; 2006 Sep; 26(9):1198-212. PubMed ID: 16421508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography.
    Koeppe RA; Frey KA; Kume A; Albin R; Kilbourn MR; Kuhl DE
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):919-31. PubMed ID: 9307605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
    Koeppe RA; Frey KA; Kuhl DE; Kilbourn MR
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
    Lee CS; Samii A; Sossi V; Ruth TJ; Schulzer M; Holden JE; Wudel J; Pal PK; de la Fuente-Fernandez R; Calne DB; Stoessl AJ
    Ann Neurol; 2000 Apr; 47(4):493-503. PubMed ID: 10762161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome.
    Meyer P; Bohnen NI; Minoshima S; Koeppe RA; Wernette K; Kilbourn MR; Kuhl DE; Frey KA; Albin RL
    Neurology; 1999 Jul; 53(2):371-4. PubMed ID: 10430428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.
    Koeppe RA; Frey KA; Vander Borght TM; Karlamangla A; Jewett DM; Lee LC; Kilbourn MR; Kuhl DE
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1288-99. PubMed ID: 8898703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of the brain vesicular monoamine transporter.
    Vander Borght TM; Kilbourn MR; Koeppe RA; DaSilva JN; Carey JE; Kuhl DE; Frey KA
    J Nucl Med; 1995 Dec; 36(12):2252-60. PubMed ID: 8523116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET.
    De La Fuente-Fernández R; Furtado S; Guttman M; Furukawa Y; Lee CS; Calne DB; Ruth TJ; Stoessl AJ
    Synapse; 2003 Jul; 49(1):20-8. PubMed ID: 12710012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo measurement of the vesicular monoamine transporter in schizophrenia.
    Taylor SF; Koeppe RA; Tandon R; Zubieta JK; Frey KA
    Neuropsychopharmacology; 2000 Dec; 23(6):667-75. PubMed ID: 11063922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography.
    Gilman S; Frey KA; Koeppe RA; Junck L; Little R; Vander Borght TM; Lohman M; Martorello S; Lee LC; Jewett DM; Kilbourn MR
    Ann Neurol; 1996 Dec; 40(6):885-92. PubMed ID: 9007093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.
    Lin SC; Lin KJ; Hsiao IT; Hsieh CJ; Lin WY; Lu CS; Wey SP; Yen TC; Kung MP; Weng YH
    J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography.
    Gilman S; Koeppe RA; Adams KM; Junck L; Kluin KJ; Johnson-Greene D; Martorello S; Heumann M; Bandekar R
    Ann Neurol; 1998 Sep; 44(3):326-33. PubMed ID: 9749598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates.
    Zubieta JK; Huguelet P; Ohl LE; Koeppe RA; Kilbourn MR; Carr JM; Giordani BJ; Frey KA
    Am J Psychiatry; 2000 Oct; 157(10):1619-28. PubMed ID: 11007716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
    Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects.
    Chan GL; Holden JE; Stoessl AJ; Samii A; Doudet DJ; Dobko T; Morrison KS; Adam M; Schulzer M; Calne DB; Ruth TJ
    J Nucl Med; 1999 Feb; 40(2):283-9. PubMed ID: 10025836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging the vesicular monoamine transporter.
    Frey KA; Koeppe RA; Kilbourn MR
    Adv Neurol; 2001; 86():237-47. PubMed ID: 11553983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
    Boileau I; Rusjan P; Houle S; Wilkins D; Tong J; Selby P; Guttman M; Saint-Cyr JA; Wilson AA; Kish SJ
    J Neurosci; 2008 Sep; 28(39):9850-6. PubMed ID: 18815269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
    Goswami R; Ponde DE; Kung MP; Hou C; Kilbourn MR; Kung HF
    Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.